• Home
  • Victims
    • Vaccine Victims Memorial
    • Gardasil & Silgard
      • G / S Australasia
        • G / S Australia
        • G / S New Zealand
      • G / S Europe
        • G / S Czech Republic
        • G / S Denmark
        • G / S France
        • G / S Germany
        • G / S Ireland
        • G / S Italy
        • G / S Norway
        • G / S Scotland
        • G / S Spain
        • G / S United Kingdom
      • G / S N. America
        • G / S Canada
        • G / S Mexico
        • G / S United States
      • G / S S. America
        • G / S Brazil
        • G/S Colombia
    • Cervarix
      • Cervarix Asia
        • Cervarix India
        • Cervarix Philippines
      • Cervarix Europe
        • Cervarix Czech
        • Cervarix Netherlands
        • Cervarix Scotland
        • Cervarix Slovakia
        • Cervarix Spain
        • Cervarix UK
      • Cervarix N. America
        • Cervarix Mexico
  • Resources
    • HPV Testing Resources
      • Pre-HPV Vaccination
      • Post-HPV Vaccination
    • Medical Professionals
    • Vaccine Injury Attorneys
    • Political Action Groups
    • Vaccine Groups
    • Vaccine Victims Hotline
  • SANE Vax Press Releases
  • Videos
    • Vaccine Safety Videos
    • Vaccine Victim Videos
    • Pharma Videos
  • About
    • About Us
    • Who We Are
    • Press Releases
    • SANE Vax in the News
    • Contact Us

SaneVax, Inc.

The First International HPV Vaccine Information Clearinghouse

  • NEWS
    • Government Agencies
      • African
      • Asian
      • Australasian
      • European
      • North American
      • South American
      • United Nations
      • WHO
    • Pharmaceutical Companies
      • CSL Biotherapies
      • GlaxoSmithKline
      • Inovio Pharmaceuticals
      • Liquidia Technologies
      • Merck & Co.
      • Novartis
      • Pfizer
      • Qiagen
      • Sanofi Aventis
      • Sanofi Pasteur MSD spmsd
      • Wyeth Laboratories
    • Science & Medicine
      • Cancer
      • Clinical Trials
      • Environmental Health
      • Heavy Metal Toxicity
      • HPV Science
      • Influenza
      • Meningitis
      • Pertussis
      • Pharmaceuticals
      • Rotavirus
      • STD’s
      • Vaccine Science
      • Women’s Health
    • Vaccine Adverse Events
    • Vaccine Injury Reporting
      • VAERS
      • VAMPSS
    • Vaccine Litigation
    • Vaccine Marketing
    • Vaccine Politics/People
    • Vaccine Victims
      • Cervarix Injuries
      • DTP/DTaP Injuries
      • Fluvax Injuries
      • Fluzone Injuries
      • Gardasil / Silgard Injuries
      • Menomune Injuries
      • MMR Injuries
      • Polio Vaccine Injuries
      • Synflorix Injuries
      • Yellow Fever Vaccine
    • Vaccines
      • Anthrax
      • Breast Cancer
      • Chicken Pox
      • Cholera
      • Combination Vaccines
      • Diphtheria
      • Hepatitis B
      • HPV
      • Influenza Vaccines
      • Malaria
      • Measles
      • Meningitis Vaccines
      • MRSA
      • Mumps
      • Norovirus
      • Pertussis Vaccines
      • Pneumococcal Disease
      • Polio
      • Rotavirus Vaccines
      • Shingles
      • Smallpox
      • TB
      • Tetanus
      • Typhoid
      • Yellow Fever Vaccine
    • Vaccines and the Media
  • WORLD NEWS
    • Africa
    • Asia
    • Australasia
    • Europe
    • North America
    • South America
  • RESEARCH
    • Cancer Research
    • Cervarix Vaccine
    • Gardasil/Silgard Vaccine
    • Human Pap. Research
    • Immunization Practices
    • Neurology
    • Vaccine Adjuvants
    • Vac. Ingredient Research
    • Vaccine Injuries
    • Vaccine Preservatives
    • Vaccine Related Research
    • Vaccine Safety
  • CITIZENS SPEAK
    • Cervical Cancer Debate
    • HPV Vax
      • Australian Concerns
      • Canadian Concerns
      • Irish Concerns
      • Spain Concerns
      • UK Concerns
      • United States Concerns

As HPV data stacks up Merck touts Gardasil for boys

July 22, 2011 By Norma Leave a Comment

By Tracy Staton Merck’s ($MRK) Gardasil journey is becoming a saga, with twists and turns all over the place. When first approved, the vaccine against human papillomavirus was tagged as a no-brainer blockbuster. But uptake of the vaccine hit a snag; after about a third of eligible girls were vaccinated, sales growth stalled. The company’s […]

Filed Under: HPV, Merck & Co., World News Tagged With: boys, genital wart protection, Merck

Gardasil Warning

July 17, 2011 By Norma Leave a Comment

By Jenny Thompson, Health Sciences International This is a warning for all parents and grandparents: Drug giant Merck wants to inject every one of your young girls and boys with Gardasil, the controversial HPV vaccine. It’s controversial, of course, because it’s been shown to prevent a few types of human papillomavirus, but it certainly is […]

Filed Under: HPV, Merck & Co., World News Tagged With: marketing, Merck, studies

Merck’s Marketing Department Declares HPV is a Disease! SaneVax Inc. Declares Gardasil a Disease

July 16, 2011 By Norma Leave a Comment

By Leslie Carol Botha, Vice President Public Relations July 16, 2011 – Merck’s well-honed marketing professionals have done it again – they have captured the attention of parents and girl’s around the country with their marketing campaign labeling HPV a disease.  Ads have appeared throughout the summer in the national newspapers like Sunday’s Parade Magazine, […]

Filed Under: Gardasil / Silgard Injuries, HPV, Merck & Co. Tagged With: adverse events, HPV disease, HPV vaccine, marketing, Merck, victims

Merck receives approval to market Gardasil, Zolinza, and Cubicin in Japan

July 6, 2011 By Norma 1 Comment

WHITEHOUSE STATION,  N.J., July 1, 2011 – Merck (NYSE: MRK), known  as MSD outside the United States and Canada,  announced today that the Japanese  Ministry of Health, Labour and Welfare (MHLW) approved three products – GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine,  Recombinant], ZOLINZA® vorinostat) and  CUBICIN® (daptomycin for injection) – […]

Filed Under: Gardasil / Silgard Injuries, Japan, Merck & Co. Tagged With: anti-cancer drug, Cubicin, Merck, MRSA, pharmaceuticals, Zolinza

Spinning the Spin Part II: Fewer girls develop cervical abnormalities after HPV vaccine

June 29, 2011 By Norma Leave a Comment

The Marketing of Scientific Research & Studies By Leslie Carol Botha, Vice President of Public Relations, SaneVax Inc. My father, once a pharmaceutical packaging salesman and now an Alzheimer’s nursing home patient whose mental clarity declined rapidly post- flu vaccination – once told me ‘never believe in everything that is advertised.’ Truer advice was never […]

Filed Under: FDA, HPV, Merck & Co., NCI, World News Tagged With: marketing campaigns, scientific research

  • « Previous Page
  • 1
  • …
  • 8
  • 9
  • 10
  • 11
  • 12
  • …
  • 20
  • Next Page »

Follow Us

SaneVax on FacebookSaneVax on TwitterSaneVax on LinkedInSaneVax on YoutubeSaneVax RSS Feed

Help Support SaneVax

Notice: We need your support. This massive research & presentation comes from a team of volunteers. We need your help to keep this critical information available.



SaneVax relies on support from participants like you. We are a 501 (c)(3) non-profit corporation, donations are tax deductible. Help keep this venue available and support the spirit – Thank you!

This Week’s Survivor

Gone After Gardasil: Megan, New Mexico

Categories

Links

  • Creating an HPV Industry
  • File a VAERS Report
  • Gardasil and Unexplained Deaths
  • HPV Industry Timeline
  • HPV Mechanisms of Action in Women
  • HPV Vaccine Fact Sheet
  • Petition: Rescind HPV Vaccine Approval
  • Presentation to the FDA
  • Supreme Court Arguments

HPV Vaccine VAERS Reports

Description 12/14/2019  TOTAL
Disabled 3,092
Deaths 523
Did Not Recover 13,072
Abnormal Smear 695
Cervical Cancer 186
Infertility 52
Life-threatening 1,001
Emergency Room 15,419
Hospitalized 6,448
Extended Hosp. Stay 304
Serious 9,497
Total Adverse Events 64,270

Access expanded report here.

Subscribe2


 

Log In

Featured Video

Alex Jones Show: Surprise Caller Exposes How Big Pharma Purchases ‘Experts’

News

SaneVax News Blog!
News

Videos

Safety • Victims • Pharma
No Genetic Epidemic

Contact

Contact S.A.N.E.Vax
S.A.N.E.VAX log thumbnail

Copyright © 2026 SaneVax, Inc. · Site by TheWebElves.com a div. of KalaRhythms.org · Log in

 

Loading Comments...